한상아 교수
- 영문이름 -
- Han Sang Ah
- 교실 -
- 외과학교실
- 전공 -
- 유방내분비학, 유전성유방암
- 연락처 -
- 02-440-8196
- 연구실 -
- 서울 강동구 상일로 17 서희빌딩 502
- E-mail -
- ivory521@naver.com
- 비고 -
- 강동 경희대학교병원
- Surgical oncology in Breast cancer, thyroid cancer
- Hereditary Breast and ovary cancer syndrome
- Hereditary Breast and ovary cancer syndrome
- 2000 부산대학교 의과대학
- 2004 성균관대학교 의학석사
- 2008 성균관대학교 의학박사
- 2004 삼성서울병원 전공의 수료
- 2005 삼성서울병원 전임의 수료
- 2006 기쁨병원 외과 과장
- 2007-2008 분당서울대병원 병원 유방외과 전임의 수료
- 2009 분당서울대병원 유방외과 진료전문의
- 2010-2012 강동경희대병원 임상조교수
- 2013-2016 강동경희대병원 임상부교수
- 2017 - 경희대학교 의과대학 부교수
- 2004 성균관대학교 의학석사
- 2008 성균관대학교 의학박사
- 2004 삼성서울병원 전공의 수료
- 2005 삼성서울병원 전임의 수료
- 2006 기쁨병원 외과 과장
- 2007-2008 분당서울대병원 병원 유방외과 전임의 수료
- 2009 분당서울대병원 유방외과 진료전문의
- 2010-2012 강동경희대병원 임상조교수
- 2013-2016 강동경희대병원 임상부교수
- 2017 - 경희대학교 의과대학 부교수
- 2000 - 대한의학회
- 2001 - 대한외과학회
- 2005 - 대한대장항문학회
- 2007 - 한국유방암학회
- 2013 - 대한갑상선내분비외과 학회
- 2001 - 대한외과학회
- 2005 - 대한대장항문학회
- 2007 - 한국유방암학회
- 2013 - 대한갑상선내분비외과 학회
- 1. BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancer. Han SA, Park WS, Jang JH, Min SY, Ryu JK, Song JY. Ann Surg Treat Res. 2014 Oct;87(4):174-9.
- 2. A genetic association analysis of polymorphisms, rs2282695 and rs12373539, in the FOSB gene and papillary thyroid cancer. Han SA, Song JY, Min SY, Park WS, Kim MJ, Chung JH, Kwon KH. Exp Ther Med. 2012 Sep;4(3):519-523.
- 3. The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study. Han SA, Kim SW, Kang E, Park SK, Ahn SH, Lee MH, Nam SJ, Han W, Bae YT, Kim HA, Cho YU, Chang MC, Paik NS, Hwang KT, Kim SJ, Noh DY, Choi DH, Noh WC, Kim LS, Kim KS, Suh YJ, Lee JE, Jung Y, Moon BI, Yang JH, Son BH, Yom CK, Kim SY, Lee H, Jung SH; KOHBRA Research Group and the Korean Breast Cancer Society.. Fam Cancer. 2013 Mar;12(1):75-81.
- 4. The Korean Hereditary Breast Cancer (KOHBRA) study: protocols and interim report. Han SA, Park SK, Ahn SH, Lee MH, Noh DY, Kim LS, Noh WC, Jung Y, Kim KS, Kim SW; Korean Breast Cancer Study Group.. Clin Oncol (R Coll Radiol). 2011 Sep;23(7):434-41.
- 5. Comparison of immunologic outcomes of laparoscopic vs open approaches in clinical stage III colorectal cancer. Han SA, Lee WY, Park CM, Yun SH, Chun HK. Int J Colorectal Dis. 2010 May;25(5):631-8.
- 6. Prognostic significance of beta-catenin in colorectal cancer with liver metastasis. Han SA, Chun H, Park CM, Kang SJ, Kim SH, Sohn D, Yun SH, Lee WY. Clin Oncol (R Coll Radiol). 2006 Dec;18(10):761-7. Erratum in: Clin Oncol (R Coll Radiol). 2007 May;19(4):270-1.
- 7. Prevalence and risk factors for atherosclerotic carotid stenosis and plaque: A population-based screening study. Woo SY, Joh JH, Han SA, Park HC. Medicine (Baltimore). 2017 Jan;96(4):e5999. Select item 27958289
- 8. WSB1 overcomes oncogene-induced senescence by targeting ATM for degradation. Kim JJ, Lee SB, Yi SY, Han SA, Kim SH, Lee JM, Tong SY, Yin P, Gao B, Zhang J, Lou Z. Cell Res. 2017 Feb;27(2):274-293.
- 9. Surgical outcomes of robotic thyroidectomy vs. conventional open thyroidectomy for papillary thyroid carcinoma. Cho JN, Park WS, Min SY, Han SA, Song JY. World J Surg Oncol. 2016 Jul 9;14(1):181.
- 10. Intraoperative indocyanine green angiography for the objective measurement of blood flow. Joh JH, Park HC, Han SA, Ahn HJ. Ann Surg Treat Res. 2016 May;90(5):279-86.
- 11. Chronic Intussusception Caused by Diffuse Large B-Cell Lymphoma in a 6-Year-Old Girl Presenting with Abdominal Pain and Constipation for 2 Months. Choi SH, Han SA, Won KY. J Korean Med Sci. 2016 Feb;31(2):321-5.
- 12. Solitary fibrous tumor of the breast: a case report and review of the literature. Rhee SJ, Ryu JK, Han SA, Won KY. J Med Ultrason (2001). 2016 Jan;43(1):125-8.
- 13. National trends for the treatment of peripheral arterial disease in Korea between 2004 and 2013. Park YY, Joh JH, Han SA, Kim SH, Cho S, Park HC, Ahn HJ. Ann Surg Treat Res. 2015 Dec;89(6):319-24.
- 14. WSB1 promotes tumor metastasis by inducing pVHL degradation. Kim JJ, Lee SB, Jang J, Yi SY, Kim SH, Han SA, Lee JM, Tong SY, Vincelette ND, Gao B, Yin P, Evans D, Choi DW, Qin B, Liu T, Zhang H, Deng M, Jen J, Zhang J, Wang L, Lou Z. Genes Dev. 2015 Nov 1;29(21):2244-57.
- 15. The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database. Kim Z, Min SY, Yoon CS, Jung KW, Ko BS, Kang E, Nam SJ, Lee S, Hur MH; Korean Breast Cancer Society. J Breast Cancer. 2015 Jun;18(2):103-11.
- 16. The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Kang E, Seong MW, Park SK, Lee JW, Lee J, Kim LS, Lee JE, Kim SY, Jeong J, Han SA, Kim SW; Korean Hereditary Breast Cancer Study Group. Breast Cancer Res Treat. 2015 May;151(1):157-68.
- 17. Multiple Symmetric Lipomatosis (Madelung's Disease) Presenting as Bilateral Huge Gynecomastia. Jang JH, Lee A, Han SA, Ryu JK, Song JY. J Breast Cancer. 2014 Dec;17(4):397-400.
- 18. A multi-institutional study of the prevalence of BRCA1 and BRCA2 large genomic rearrangements in familial breast cancer patients. Seong MW, Cho SI, Kim KH, Chung IY, Kang E, Lee JW, Park SK, Lee MH, Choi DH, Yom CK, Noh WC, Chang MC, Park SS, Kim SW; Korean Hereditary Breast Cancer Study Group. BMC Cancer. 2014 Sep 1;14:645.
- 19. A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients. Seong MW, Kim KH, Chung IY, Kang E, Lee JW, Park SK, Lee MH, Lee JE, Noh DY, Son BH, Park HL, Cho SI, Park SS; Korean Hereditary Breast Cancer Study Group., Kim SW. Breast Cancer Res Treat. 2014 Jul;146(1):63-9.
- 20. The protective effect of parity in hormone receptor-positive, Ki-67 expressing breast cancer. Lee SK, Kim SW, Han SA, Kil WH, Lee JE, Nam SJ. World J Surg. 2014 May;38(5):1065-9.
- 21. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study. Son BH, Ahn SH, Kim SW, Kang E, Park SK, Lee MH, Noh WC, Kim LS, Jung Y, Kim KS, Noh DY, Moon BI, Suh YJ, Lee JE, Choi DH, Kim SY, Jung SH, Yom CK, Lee H, Yang JH; KOHBRA Research Group and Korean Breast Cancer Society.. Breast Cancer Res Treat. 2012 Jun;133(3):1143-52.
- 22. Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy. Kang E, Chung IY, Han SA, Kim SM, Jang M, Lyou CY, Park SY, Kim JH, Kim YJ, Kim SW. J Breast Cancer. 2011 Jun;14(2):147-52.
- 23. Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer. Won KY, Lim SJ, Kim GY, Kim YW, Han SA, Song JY, Lee DK. Hum Pathol. 2012 Feb;43(2):221-8.
- 24. Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study. Kang E, Yang EJ, Kim SM, Chung IY, Han SA, Ku DH, Nam SJ, Yang JH, Kim SW. Support Care Cancer. 2012 Mar;20(3):461-73.
- 2. A genetic association analysis of polymorphisms, rs2282695 and rs12373539, in the FOSB gene and papillary thyroid cancer. Han SA, Song JY, Min SY, Park WS, Kim MJ, Chung JH, Kwon KH. Exp Ther Med. 2012 Sep;4(3):519-523.
- 3. The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study. Han SA, Kim SW, Kang E, Park SK, Ahn SH, Lee MH, Nam SJ, Han W, Bae YT, Kim HA, Cho YU, Chang MC, Paik NS, Hwang KT, Kim SJ, Noh DY, Choi DH, Noh WC, Kim LS, Kim KS, Suh YJ, Lee JE, Jung Y, Moon BI, Yang JH, Son BH, Yom CK, Kim SY, Lee H, Jung SH; KOHBRA Research Group and the Korean Breast Cancer Society.. Fam Cancer. 2013 Mar;12(1):75-81.
- 4. The Korean Hereditary Breast Cancer (KOHBRA) study: protocols and interim report. Han SA, Park SK, Ahn SH, Lee MH, Noh DY, Kim LS, Noh WC, Jung Y, Kim KS, Kim SW; Korean Breast Cancer Study Group.. Clin Oncol (R Coll Radiol). 2011 Sep;23(7):434-41.
- 5. Comparison of immunologic outcomes of laparoscopic vs open approaches in clinical stage III colorectal cancer. Han SA, Lee WY, Park CM, Yun SH, Chun HK. Int J Colorectal Dis. 2010 May;25(5):631-8.
- 6. Prognostic significance of beta-catenin in colorectal cancer with liver metastasis. Han SA, Chun H, Park CM, Kang SJ, Kim SH, Sohn D, Yun SH, Lee WY. Clin Oncol (R Coll Radiol). 2006 Dec;18(10):761-7. Erratum in: Clin Oncol (R Coll Radiol). 2007 May;19(4):270-1.
- 7. Prevalence and risk factors for atherosclerotic carotid stenosis and plaque: A population-based screening study. Woo SY, Joh JH, Han SA, Park HC. Medicine (Baltimore). 2017 Jan;96(4):e5999. Select item 27958289
- 8. WSB1 overcomes oncogene-induced senescence by targeting ATM for degradation. Kim JJ, Lee SB, Yi SY, Han SA, Kim SH, Lee JM, Tong SY, Yin P, Gao B, Zhang J, Lou Z. Cell Res. 2017 Feb;27(2):274-293.
- 9. Surgical outcomes of robotic thyroidectomy vs. conventional open thyroidectomy for papillary thyroid carcinoma. Cho JN, Park WS, Min SY, Han SA, Song JY. World J Surg Oncol. 2016 Jul 9;14(1):181.
- 10. Intraoperative indocyanine green angiography for the objective measurement of blood flow. Joh JH, Park HC, Han SA, Ahn HJ. Ann Surg Treat Res. 2016 May;90(5):279-86.
- 11. Chronic Intussusception Caused by Diffuse Large B-Cell Lymphoma in a 6-Year-Old Girl Presenting with Abdominal Pain and Constipation for 2 Months. Choi SH, Han SA, Won KY. J Korean Med Sci. 2016 Feb;31(2):321-5.
- 12. Solitary fibrous tumor of the breast: a case report and review of the literature. Rhee SJ, Ryu JK, Han SA, Won KY. J Med Ultrason (2001). 2016 Jan;43(1):125-8.
- 13. National trends for the treatment of peripheral arterial disease in Korea between 2004 and 2013. Park YY, Joh JH, Han SA, Kim SH, Cho S, Park HC, Ahn HJ. Ann Surg Treat Res. 2015 Dec;89(6):319-24.
- 14. WSB1 promotes tumor metastasis by inducing pVHL degradation. Kim JJ, Lee SB, Jang J, Yi SY, Kim SH, Han SA, Lee JM, Tong SY, Vincelette ND, Gao B, Yin P, Evans D, Choi DW, Qin B, Liu T, Zhang H, Deng M, Jen J, Zhang J, Wang L, Lou Z. Genes Dev. 2015 Nov 1;29(21):2244-57.
- 15. The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database. Kim Z, Min SY, Yoon CS, Jung KW, Ko BS, Kang E, Nam SJ, Lee S, Hur MH; Korean Breast Cancer Society. J Breast Cancer. 2015 Jun;18(2):103-11.
- 16. The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Kang E, Seong MW, Park SK, Lee JW, Lee J, Kim LS, Lee JE, Kim SY, Jeong J, Han SA, Kim SW; Korean Hereditary Breast Cancer Study Group. Breast Cancer Res Treat. 2015 May;151(1):157-68.
- 17. Multiple Symmetric Lipomatosis (Madelung's Disease) Presenting as Bilateral Huge Gynecomastia. Jang JH, Lee A, Han SA, Ryu JK, Song JY. J Breast Cancer. 2014 Dec;17(4):397-400.
- 18. A multi-institutional study of the prevalence of BRCA1 and BRCA2 large genomic rearrangements in familial breast cancer patients. Seong MW, Cho SI, Kim KH, Chung IY, Kang E, Lee JW, Park SK, Lee MH, Choi DH, Yom CK, Noh WC, Chang MC, Park SS, Kim SW; Korean Hereditary Breast Cancer Study Group. BMC Cancer. 2014 Sep 1;14:645.
- 19. A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients. Seong MW, Kim KH, Chung IY, Kang E, Lee JW, Park SK, Lee MH, Lee JE, Noh DY, Son BH, Park HL, Cho SI, Park SS; Korean Hereditary Breast Cancer Study Group., Kim SW. Breast Cancer Res Treat. 2014 Jul;146(1):63-9.
- 20. The protective effect of parity in hormone receptor-positive, Ki-67 expressing breast cancer. Lee SK, Kim SW, Han SA, Kil WH, Lee JE, Nam SJ. World J Surg. 2014 May;38(5):1065-9.
- 21. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study. Son BH, Ahn SH, Kim SW, Kang E, Park SK, Lee MH, Noh WC, Kim LS, Jung Y, Kim KS, Noh DY, Moon BI, Suh YJ, Lee JE, Choi DH, Kim SY, Jung SH, Yom CK, Lee H, Yang JH; KOHBRA Research Group and Korean Breast Cancer Society.. Breast Cancer Res Treat. 2012 Jun;133(3):1143-52.
- 22. Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy. Kang E, Chung IY, Han SA, Kim SM, Jang M, Lyou CY, Park SY, Kim JH, Kim YJ, Kim SW. J Breast Cancer. 2011 Jun;14(2):147-52.
- 23. Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer. Won KY, Lim SJ, Kim GY, Kim YW, Han SA, Song JY, Lee DK. Hum Pathol. 2012 Feb;43(2):221-8.
- 24. Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study. Kang E, Yang EJ, Kim SM, Chung IY, Han SA, Ku DH, Nam SJ, Yang JH, Kim SW. Support Care Cancer. 2012 Mar;20(3):461-73.